• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含杂原子的维甲酸类化合物的提纯

Refining retinoids with heteroatoms.

作者信息

Benbrook D M

机构信息

Department of Obstetrics and Gynecology, The University of Oklahoma Health Science Center, P.O. Box 26901, Room WP2470, Oklahoma City, OK 73190, USA.

出版信息

Mini Rev Med Chem. 2002 Jun;2(3):277-83. doi: 10.2174/1389557023406160.

DOI:10.2174/1389557023406160
PMID:12370069
Abstract

Retinoids are a group of synthetic compounds designed to refine the numerous biological activities of retinoic acid into pharmaceuticals for several diseases, including cancer. Designs that conformationally-restricted the rotation of the structures resulted in arotinoids that were biologically active, but with increased toxicity. Incorporation of a heteroatom in one cyclic ring of the arotinoid structures drastically reduced the toxicity, while retaining biological activity. Clinical trials of a heteroarotinoid, Tazarotene, confirmed the improved chemotherapeutic ratio (efficacy/toxicity).

摘要

类视黄醇是一类合成化合物,旨在将视黄酸的多种生物活性提炼成用于治疗包括癌症在内的多种疾病的药物。对结构旋转进行构象限制的设计产生了具有生物活性但毒性增加的芳维甲酸类化合物。在芳维甲酸类化合物结构的一个环中引入杂原子可大幅降低毒性,同时保留生物活性。一种杂芳维甲酸类化合物他扎罗汀的临床试验证实了化疗指数(疗效/毒性)得到改善。

相似文献

1
Refining retinoids with heteroatoms.含杂原子的维甲酸类化合物的提纯
Mini Rev Med Chem. 2002 Jun;2(3):277-83. doi: 10.2174/1389557023406160.
2
Comparative teratogenic activity of cancer chemopreventive retinoidal benzoic acid congeners (arotinoids).癌症化学预防类视黄酸苯甲酸类似物(芳维甲酸类)的比较致畸活性
J Natl Cancer Inst. 1987 Mar;78(3):533-8.
3
Biologically active heteroarotinoids exhibiting anticancer activity and decreased toxicity.具有抗癌活性且毒性降低的生物活性杂芳维甲酸类化合物。
J Med Chem. 1997 Oct 24;40(22):3567-83. doi: 10.1021/jm970196m.
4
Heterocycle-containing retinoids. Discovery of a novel isoxazole arotinoid possessing potent apoptotic activity in multidrug and drug-induced apoptosis-resistant cells.含杂环的类视黄醇。一种新型异恶唑类视黄醛的发现,其在多药耐药和药物诱导的凋亡抗性细胞中具有强大的凋亡活性。
J Med Chem. 2001 Jul 5;44(14):2308-18. doi: 10.1021/jm0010320.
5
Conformationally defined 6-s-trans-retinoic acid analogs. 3. Structure-activity relationships for nuclear receptor binding, transcriptional activity, and cancer chemopreventive activity.构象明确的6-s-反式维甲酸类似物。3. 核受体结合、转录活性和癌症化学预防活性的构效关系。
J Med Chem. 1996 Sep 13;39(19):3625-35. doi: 10.1021/jm9603126.
6
Synthesis and characterization of heteroarotinoids demonstrate structure specificity relationships.
J Med Chem. 1998 Sep 10;41(19):3753-7. doi: 10.1021/jm980308p.
7
Design and stereoselective synthesis of retinoids with ferrocene or N-butylcarbazole pharmacophores that induce post-differentiation apoptosis in acute promyelocytic leukemia cells.具有二茂铁或 N-正丁基咔唑药效团的视黄酸的设计和立体选择性合成,可诱导急性早幼粒细胞白血病细胞的分化后凋亡。
ChemMedChem. 2011 Aug 1;6(8):1518-29. doi: 10.1002/cmdc.201100065. Epub 2011 Apr 19.
8
Novel synthetic retinoids and separation of the pleiotropic retinoidal activities.新型合成类视黄醇与多效视黄醇活性的分离
Curr Med Chem. 2002 Mar;9(5):591-608. doi: 10.2174/0929867024606975.
9
The arotinoids: early clinical experience and discussion of future development.芳香维甲酸类药物:早期临床经验及未来发展探讨
Leukemia. 1994;8 Suppl 3:S42-9.
10
Synthetic retinoids: recent developments concerning structure and clinical utility.合成维甲酸:关于结构与临床应用的最新进展
J Med Chem. 2005 Sep 22;48(19):5875-83. doi: 10.1021/jm0581821.

引用本文的文献

1
Synthetic and Natural Inhibitors of Mortalin for Cancer Therapy.用于癌症治疗的Mortalin的合成和天然抑制剂
Cancers (Basel). 2024 Oct 13;16(20):3470. doi: 10.3390/cancers16203470.
2
SHetA2 interference with mortalin binding to p66shc and p53 identified using drug-conjugated magnetic microspheres.使用药物偶联磁性微球鉴定SHetA2对mortalin与p66shc和p53结合的干扰作用。
Invest New Drugs. 2014 Jun;32(3):412-23. doi: 10.1007/s10637-013-0041-x. Epub 2013 Nov 20.
3
Gene expression analysis of biological systems driving an organotypic model of endometrial carcinogenesis and chemoprevention.
驱动子宫内膜癌发生和化学预防器官型模型的生物系统的基因表达分析。
Gene Regul Syst Bio. 2008;2:21-42. doi: 10.4137/grsb.s344.
4
Heteroarotinoids with anti-cancer activity against ovarian cancer cells.对卵巢癌细胞具有抗癌活性的杂芳维甲酸类化合物。
Open Med Chem J. 2007 Oct 24;1:11-23. doi: 10.2174/1874104500701010011.
5
Flexible heteroarotinoids (Flex-Hets) exhibit improved therapeutic ratios as anti-cancer agents over retinoic acid receptor agonists.与维甲酸受体激动剂相比,柔性杂芳维甲酸类化合物(Flex-Hets)作为抗癌药物具有更高的治疗指数。
Invest New Drugs. 2005 Oct;23(5):417-28. doi: 10.1007/s10637-005-2901-5.